ArticleArchives of medical science : AMS2025

Rosuvastatin-based combination treatment with acetylsalicylic acid or ezetimibe in the management of patients at high and very high cardiovascular risk. Expert opinion paper of the Polish Lipid Association 2025.

Maciej Banach et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.